Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.99.5 (
NADH dehydrogenase
)
2,135
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hereditary spastic paraplegias, a group of neurodegenerative disorders, can be caused by loss-of-function mutations in the protein
spartin
. However, the physiological role of
spartin
remains largely elusive. Here we show that heterologous expression of human or
Drosophila
spartin
extends chronological lifespan of yeast, reducing age-associated ROS production, apoptosis, and necrosis. We demonstrate that
spartin
localizes to the proximity of mitochondria and physically interacts with proteins related to mitochondrial and respiratory metabolism. Interestingly, Nde1, the mitochondrial external
NADH dehydrogenase
, and Pda1, the core enzyme of the pyruvate dehydrogenase complex, are required for
spartin
-mediated cytoprotection. Furthermore,
spartin
interacts with the glycolysis enhancer phospo-fructo-kinase-2,6 (Pfk26) and is sufficient to complement for
PFK26
-deficiency at least in early aging. We conclude that mitochondria-related energy metabolism is crucial for
spartin
's vital function during aging and uncover a network of specific interactors required for this function.
...
PMID:Mitochondrial energy metabolism is required for lifespan extension by the spastic paraplegia-associated protein spartin. 2923 70